RBFC
Roman Butler Fullerton & Co Portfolio holdings
AUM
$339M
This Quarter Return
-3.72%
1 Year Return
+24.9%
3 Year Return
+114.14%
5 Year Return
+206.87%
10 Year Return
–
AUM
$157M
AUM Growth
+$157M
(-13%)
Cap. Flow
-$1.93M
Cap. Flow
% of AUM
-1.23%
Top 10 Holdings %
Top 10 Hldgs %
28.08%
Holding
185
New
10
Increased
94
Reduced
47
Closed
16
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$2.69M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$1.44M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$1.35M |
| 4 |
Neurocrine Biosciences
NBIX
|
$1.14M |
| 5 |
Molina Healthcare
MOH
|
$1.08M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$1.57M |
| 2 |
NVIDIA
NVDA
|
$1.54M |
| 3 |
Microsoft
MSFT
|
$1.25M |
| 4 |
Deere & Co
DE
|
$1.01M |
| 5 |
Fidelity MSCI Financials Index ETF
FNCL
|
$971K |
Sector Composition
| 1 | Technology | 16.56% |
| 2 | Healthcare | 15.78% |
| 3 | Financials | 8.85% |
| 4 | Consumer Staples | 7.56% |
| 5 | Consumer Discretionary | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$96B
| $1.41M | 0.9% |
20,290
+96
| +0.5% | +$6.69K |
|
27
Lowe's Companies
LOW
$145B
| $1.4M | 0.89% |
7,135
+49
| +0.7% | +$9.62K |
|
|
28
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.35M | 0.86% |
+1,826
| New | +$1.35M |
|
29
iShares Core S&P 500 ETF
IVV
$662B
| $1.34M | 0.85% |
3,731
-63
| -2% | -$22.6K |
|
|
IGR
30
CBRE Global Real Estate Income Fund
IGR
$717M
| $1.31M | 0.83% |
232,072
+27,499
| +13% | +$155K |
|
31
Datadog
DDOG
$47.7B
| $1.26M | 0.8% |
15,177
| – | – |
|
32
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $1.25M | 0.79% |
18,805
+31
| +0.2% | +$2.05K |
|
33
Abbott
ABT
$231B
| $1.24M | 0.79% |
12,206
+11
| +0.1% | +$1.12K |
|
34
Diamondback Energy
FANG
$43.1B
| $1.24M | 0.79% |
8,880
-4,788
| -35% | -$668K |
|
35
Dollar General
DG
$23.9B
| $1.23M | 0.78% |
5,138
+46
| +0.9% | +$11K |
|
|
36
Neurocrine Biosciences
NBIX
$13.8B
| $1.14M | 0.72% |
+10,559
| New | +$1.14M |
|
37
Ameren
AEE
$27B
| $1.11M | 0.71% |
14,246
+15
| +0.1% | +$1.17K |
|
38
JPMorgan Chase
JPM
$829B
| $1.1M | 0.7% |
10,799
+371
| +4% | +$37.8K |
|
|
EOS
39
Eaton Vance Enhance Equity Income Fund II
EOS
$1.27B
| $1.09M | 0.69% |
70,672
+9,132
| +15% | +$141K |
|
40
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.09M | 0.69% |
12,381
+2,019
| +19% | +$178K |
|
|
41
Molina Healthcare
MOH
$9.8B
| $1.08M | 0.68% |
+3,054
| New | +$1.08M |
|
42
CVS Health
CVS
$92.8B
| $1.07M | 0.68% |
12,122
-62
| -0.5% | -$5.49K |
|
43
iShares Core Dividend Growth ETF
DGRO
$33.7B
| $1.05M | 0.67% |
23,504
+402
| +2% | +$17.9K |
|
44
Merck
MRK
$210B
| $1.05M | 0.67% |
11,526
+46
| +0.4% | +$4.19K |
|
45
Valero Energy
VLO
$47.2B
| $1.05M | 0.67% |
9,560
-63
| -0.7% | -$6.91K |
|
46
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.03M | 0.65% |
2,879
+2,237
| +348% | +$800K |
|
47
Emerson Electric
EMR
$74.3B
| $1.01M | 0.64% |
12,887
+3,009
| +30% | +$235K |
|
48
Day Hagan/Ned Davis Research Smart Sector ETF
SSUS
$560M
| $985K | 0.63% |
34,117
-16,220
| -32% | -$468K |
|
49
PepsiCo
PEP
$204B
| $980K | 0.62% |
6,030
+13
| +0.2% | +$2.11K |
|
50
Parker-Hannifin
PH
$96.2B
| $971K | 0.62% |
3,808
-66
| -2% | -$16.8K |
|